Hi TV,Thanks for posting. Very insightful interviews. 1. Based...

Hi TV,
Thanks for posting. Very insightful interviews.
1. Based on ATAI valuation (cash equivalents - 25%), IHL should trade between 2 and 3 cents. Still a long way to go.
2. When the turnaround happens IHL will spin its wheels as little cash to develop programs. $30million wont go far = Dilution.
3. Wouldn't you love a CEO like Angermayer - all over the strategy and doesn't have to read a cue card to answer prepped questions (refer to slide 26 blah blah). Raising money obviously no big deal for him, war chest > $400,000,000.
4. IHL already late to the party for clinics in US. Might be some upside in Australia but this is peanuts compared to what is required to get FDA approval.
Regards